(Q35790890)

10 August 2017

1 reference

title

Therapeutic idiotype vaccines in B lymphoproliferative diseases (English)

1 reference

10 August 2017

2

Larry W Kwak

1 reference

10 August 2017

Marta Coscia

1

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Expert Opinion on Biological Therapy

10 August 2017

published in

1 reference

10 August 2017

volume

4

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

959-963

1 reference

Myeloma proteins as tumor-specific transplantation antigens

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.959

Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.959

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.959

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.959

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.959

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.959

Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.959

Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.959

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.959

Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.959

Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.959

21 January 2018

Identifiers

DOI

10.1517/14712598.4.6.959

1 reference

10 August 2017

1 reference